Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-25

Clinical Trial Update: Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of the fixed-dose combination Telmisartan/Amlodipine/Rosuvastatin in hypertensive patients with hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Rosuvastatin (rosuvastatin)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypertension With Hyperlipidemia | Phase 3 | Status: COMPLETED